Maravai LifeSciences Holdings, Inc.
MRVI
$3.51
$0.072.04%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -12.17% | 1.17% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -12.17% | 1.17% | |||
| Cost of Revenue | -9.22% | 1.29% | |||
| Gross Profit | -27.20% | 0.56% | |||
| SG&A Expenses | -8.24% | -2.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.47% | -0.59% | |||
| Operating Income | 5.90% | 2.83% | |||
| Income Before Tax | 39.09% | -40.68% | |||
| Income Tax Expenses | 97.85% | -2,746.91% | |||
| Earnings from Continuing Operations | 35.48% | -32.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -35.53% | 32.03% | |||
| Net Income | 35.45% | -32.21% | |||
| EBIT | 5.90% | 2.83% | |||
| EBITDA | 9.46% | 6.13% | |||
| EPS Basic | 35.66% | -31.47% | |||
| Normalized Basic EPS | -233.81% | 233.76% | |||
| EPS Diluted | 35.66% | -31.47% | |||
| Normalized Diluted EPS | -233.81% | 233.76% | |||
| Average Basic Shares Outstanding | 0.31% | 0.57% | |||
| Average Diluted Shares Outstanding | 0.31% | 0.57% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||